Arcadia Biosciences Financials
| RKDA Stock | USD 3.91 0.05 1.30% |
Arcadia |
Please note, the presentation of Arcadia Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Arcadia Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Arcadia Biosciences' management manipulating its earnings.
Arcadia Biosciences Stock Summary
Arcadia Biosciences competes with Better Choice, Bit Origin, Farmmi, Laird Superfood, and Planet Green. Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. The company was incorporated in 2002 and is headquartered in Davis, California. Arcadia Bio operates under Agricultural Inputs classification in the United States and is traded on NASDAQ Exchange. It employs 58 people.Specialization | Consumer Defensive, Food, Beverage & Tobacco |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US0390142042 |
| CUSIP | 039014204 039014105 039014303 |
| Location | United States; U.S.A |
| Business Address | 5950 Sherry Lane, |
| Sector | Food Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.arcadiabio.com |
| Phone | 214 974 8921 |
| Currency | USD - US Dollar |
Arcadia Biosciences Key Financial Ratios
Arcadia Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Arcadia Biosciences's current stock value. Our valuation model uses many indicators to compare Arcadia Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arcadia Biosciences competition to find correlations between indicators driving Arcadia Biosciences's intrinsic value. More Info.Arcadia Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arcadia Biosciences' earnings, one of the primary drivers of an investment's value.Arcadia Biosciences Systematic Risk
Arcadia Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Arcadia Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Arcadia Biosciences correlated with the market. If Beta is less than 0 Arcadia Biosciences generally moves in the opposite direction as compared to the market. If Arcadia Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Arcadia Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Arcadia Biosciences is generally in the same direction as the market. If Beta > 1 Arcadia Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
About Arcadia Biosciences Financials
What exactly are Arcadia Biosciences Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Arcadia Biosciences' income statement, its balance sheet, and the statement of cash flows. Potential Arcadia Biosciences investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Arcadia Biosciences investors may use each financial statement separately, they are all related. The changes in Arcadia Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Arcadia Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Arcadia Biosciences Thematic Clasifications
Arcadia Biosciences is part of several thematic ideas from Natural Foods to Processed Foods. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasArcadia Biosciences March 1, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Arcadia Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Arcadia Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Arcadia Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Arcadia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Arcadia Biosciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.98 | |||
| Information Ratio | 0.0882 | |||
| Maximum Drawdown | 122.81 | |||
| Value At Risk | (5.82) | |||
| Potential Upside | 5.96 |
Complementary Tools for Arcadia Stock analysis
When running Arcadia Biosciences' price analysis, check to measure Arcadia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcadia Biosciences is operating at the current time. Most of Arcadia Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcadia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcadia Biosciences' price. Additionally, you may evaluate how the addition of Arcadia Biosciences to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stocks Directory Find actively traded stocks across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world |